Back
Loncar Cancer Immunotherapy ETF 10K Form
Sell
50
CNCR
Loncar Cancer Immunotherapy ETF
Last Price:
15.44
Seasonality Move:
1.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CNCR News And Ratings
See the #1 stock for the next 7 days that we like better than CNCR
CNCR Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Loncar Cancer Immunotherapy ETF Earnings Forecast
Key Loncar Cancer Immunotherapy ETF Financial Ratios
Loncar Cancer Immunotherapy ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | CNCR |
| CUSIP: | 26922A |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CNCR Technical Analysis vs Fundamental Analysis
Sell
50
Loncar Cancer Immunotherapy ETF (CNCR)
is a Sell
Is Loncar Cancer Immunotherapy ETF a Buy or a Sell?
-
Loncar Cancer Immunotherapy ETF stock is rated a Sell
The current Loncar Cancer Immunotherapy ETF [CNCR] share price is $15.44. The Score for CNCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.